LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study
暂无分享，去创建一个
I. Sobhani | A. Lièvre | C. Lepage | E. Assenat | D. Smith | P. Niccoli | M. Perrier | L. Mineur | R. Coriat | F. Di Fioré | D. Malka | K. Le Malicot | T. Walter | L. Dahan | V. Hautefeuille | F. El Hajbi | G. Roquin | C. L. Bohas | O. H. Dhome | V. Granger